Gaps in HIV prevention expose Europe to risk of outbreaks
In Europe, decades of investment in effective HIV prevention measures targeting people who inject drugs continue to bear fruit as demonstrated by the long-term decline HIV diagnoses related to drug injecting. Over the past ten years, the rate of newly reported HIV diagnoses attributed to injecting drug use in the EU, Turkey and Norway has more than halved from 52 per million population in 2004 (2644 cases) to 25 in 2013 (1458 cases).
